ArticleJournal of neuro-oncology2026
Dosimetric and spatial impact of high-resolution SPACE MRI on target delineation for glomus tumor radiosurgery: a retrospective cohort study.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate sequence-dependent volumetric, spatial, and dosimetric discrepancies between standard T1c gradient-recalled echo and high-resolution T1c turbo spin-echo (SPACE) sequences for stereotactic radiosurgery of glomus jugulare tumors.
methodsWe retrospectively analyzed 47 patients undergoing Gamma Knife radiosurgery for glomus tumors. Pre-treatment 1.5T MRI included T1c MPRAGE and T1c SPACE sequences acquired during a single session. Gross tumor volumes (GTV) were delineated by multidisciplinary consensus. Geometric variances were quantified using the Dice Similarity Coefficient (DSC) and 95% Hausdorff Distance (HD95). A three-phase dosimetric analysis evaluated the clinical T1c-optimized plan, the hypothetical target coverage (V100%) variance when applying the unchanged T1c plan to the SPACE target, and a corrective SPACE-optimized research replan.
resultsMedian SPACE-derived GTVs (10.67 cm³) were significantly larger than T1c-derived GTVs (9.51 cm³, p < 0.001). Volumetric expansion occurred predominantly at the peripheral tumor-vessel interface. The median DSC was 0.917 and HD95 was 1.89 mm. Applying clinical T1c plans to SPACE targets produced a sequence-dependent geographic discrepancy, reducing hypothetical V100% coverage from 95.6% to 91.0% (p < 0.001). Corrective replanning with SPACE targets restored coverage while significantly lowering brainstem and cochlear organ-at-risk doses (p < 0.001), though this may partially reflect retrospective optimization bias.
conclusionMRI sequence selection fundamentally alters GTV delineation and dosimetric parameters in glomus radiosurgery. Flow-suppressed SPACE sequences consistently yield larger target volumes at the complex tumor-vessel interface, mathematically reducing target coverage against conventional T1c planning. Lacking a definitive pathological benchmark, the true clinical significance of these specific contour discrepancies requires prospective oncological validation.
Indexed as
Identifiers
42517943What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.